98 related articles for article (PubMed ID: 10374463)
1. [Drug resistance mechanism of doxorubicin-resistant human gastric cancer cells BGC-823/DOX].
Zheng G; Han F; Liu X
Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):325-8. PubMed ID: 10374463
[TBL] [Abstract][Full Text] [Related]
2. Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres.
Laurand A; Laroche-Clary A; Larrue A; Huet S; Soma E; Bonnet J; Robert J
Anticancer Res; 2004; 24(6):3781-8. PubMed ID: 15736412
[TBL] [Abstract][Full Text] [Related]
3. [Molecular biological evidence for the genetic stability of in vivo passaged doxorubicin resistant cell line S-180R].
Zheng G; Zhang T; Han F
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):40-2. PubMed ID: 10921055
[TBL] [Abstract][Full Text] [Related]
4. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
Kim R; Ohi Y; Inoue H; Aogi K; Toge T
Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and characterization of doxorubicin-resistant BGC-823/DOX of human gastric cancer cell line].
Zheng G; Liu X; Han F
Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):262-4. PubMed ID: 10374555
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
[TBL] [Abstract][Full Text] [Related]
7. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
[TBL] [Abstract][Full Text] [Related]
9. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
10. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
[TBL] [Abstract][Full Text] [Related]
11. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells.
He Z; Hu B; Tang L; Zheng S; Sun Y; Sheng Z; Yao Y; Lin F
J Cancer Res Ther; 2015; 11(1):18-23. PubMed ID: 25879330
[TBL] [Abstract][Full Text] [Related]
12. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin.
Bader P; Fuchs J; Wenderoth M; von Schweinitz D; Niethammer D; Beck JF
Anticancer Res; 1998; 18(4C):3127-32. PubMed ID: 9713521
[TBL] [Abstract][Full Text] [Related]
14. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
15. Infection by Cx43 adenovirus increased chemotherapy sensitivity in human gastric cancer BGC-823 cells: not involving in induction of cell apoptosis.
Liu D; Zhou H; Wu J; Liu W; Li Y; Shi G; Yue X; Sun X; Zhao Y; Hu X; Wang T; Zhang X
Gene; 2015 Dec; 574(2):217-24. PubMed ID: 26318481
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
[TBL] [Abstract][Full Text] [Related]
19. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.
Ogretmen B; Bahadori H; McCauley M; Boylan A; Green M; Safa AR
Cancer Chemother Pharmacol; 1998; 42(6):441-6. PubMed ID: 9788569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
